Anti-angiogenic agents in ovarian cancer: dawn of a new era?

J Liu, UA Matulonis - Current oncology reports, 2011 - Springer
Epithelial ovarian cancer is a leading cause of cancer-related death for women both in the
United States and worldwide, and the effectiveness of cytotoxic chemotherapy has …
被引用次数：26 相关文章

Anti-angiogenic agents in ovarian cancer: dawn of a new era?

J Liu, UA Matulonis - Current Oncology Reports, 2011 - europepmc.org
Epithelial ovarian cancer is a leading cause of cancer-related death for women both in the
United States and worldwide, and the effectiveness of cytotoxic chemotherapy has …

Anti-angiogenic Agents in Ovarian Cancer: Dawn of a New Era?

J Liu, UA Matulonis - Current Oncology Reports, 2011 - infona.pl
Epithelial ovarian cancer is a leading cause of cancer-related death for women both in the
United States and worldwide, and the effectiveness of cytotoxic chemotherapy has …

Anti-angiogenic agents in ovarian cancer: dawn of a new era?

J Liu, UA Matulonis - Current oncology reports, 2011 - pubmed.ncbi.nlm.nih.gov
Epithelial ovarian cancer is a leading cause of cancer-related death for women both in the
United States and worldwide, and the effectiveness of cytotoxic chemotherapy has …

[引用][C] Anti-angiogenic Agents in Ovarian Cancer: Dawn of a New Era?

J Liu, UA Matulonis - Current Oncology Reports, 2011 - cir.nii.ac.jp

[引用][C] Anti-angiogenic Agents in Ovarian Cancer: Dawn of a New Era?

J Liu, UA Matulonis - Current Oncology Reports, 2011 - Springer